Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.
2.

UK malaria treatment guidelines.

Lalloo DG, Shingadia D, Pasvol G, Chiodini PL, Whitty CJ, Beeching NJ, Hill DR, Warrell DA, Bannister BA; HPA Advisory Committee on Malaria Prevention in UK Travellers.

J Infect. 2007 Feb;54(2):111-21. Epub 2007 Jan 9.

PMID:
17215045
3.

Anti-malarial prescriptions in three health care facilities after the emergence of chloroquine resistance in Niakhar, Senegal (1992-2004).

Munier A, Diallo A, Cot M, Ndiaye O, Arduin P, Chippaux JP.

Malar J. 2009 Apr 27;8:83. doi: 10.1186/1475-2875-8-83.

5.

Low efficacy of chloroquine: time to switchover to artemisinin-based combination therapy for falciparum malaria in India.

Valecha N, Joshi H, Mallick PK, Sharma SK, Kumar A, Tyagi PK, Shahi B, Das MK, Nagpal BN, Dash AP.

Acta Trop. 2009 Jul;111(1):21-8. doi: 10.1016/j.actatropica.2009.01.013. Epub 2009 Feb 7.

PMID:
19426658
6.

Review of the prevalence of malaria in Zimbabwe with specific reference to parasite drug resistance (1984-96).

Makono R, Sibanda S.

Trans R Soc Trop Med Hyg. 1999 Sep-Oct;93(5):449-52. Review.

PMID:
10696392
7.

The public health impact of chloroquine resistance in Africa.

Trape JF.

Am J Trop Med Hyg. 2001 Jan-Feb;64(1-2 Suppl):12-7. Review.

8.

High Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine in Harper, Liberia: results in vivo and analysis of point mutations.

Checchi F, Durand R, Balkan S, Vonhm BT, Kollie JZ, Biberson P, Baron E, Le Bras J, Guthmann JP.

Trans R Soc Trop Med Hyg. 2002 Nov-Dec;96(6):664-9.

PMID:
12625147
9.

Evaluation of chloroquine (CQ) and sulphadoxine/pyrimethamine (SP) therapy in uncomplicated falciparum malaria in Indo-Myanmar border areas.

Mohapatra PK, Prakash A, Taison K, Negmu K, Gohain AC, Namchoom NS, Wange D, Bhattacharyya DR, Goswami BK, Borgohain BK, Mahanta J.

Trop Med Int Health. 2005 May;10(5):478-83.

10.
11.

Increasing antimalarial drug resistance in Uganda and revision of the national drug policy.

Kamya MR, Bakyaita NN, Talisuna AO, Were WM, Staedke SG.

Trop Med Int Health. 2002 Dec;7(12):1031-41.

12.

Efficacy of amodiaquine for uncomplicated Plasmodium falciparum malaria in Harper, Liberia.

Checchi F, Balkan S, Vonhm BT, Massaquoi M, Biberson P, Eldin de Pecoulas P, Brasseur P, Guthmann JP.

Trans R Soc Trop Med Hyg. 2002 Nov-Dec;96(6):670-3.

PMID:
12625148
13.

Chloroquine blood concentrations and molecular markers of chloroquine-resistant Plasmodium falciparum in febrile children in northern Ghana.

Ehrhardt S, Mockenhaupt FP, Eggelte TA, Agana-Nsiire P, Stollberg K, Anemana SD, Otchwemah RN, Bienzle U.

Trans R Soc Trop Med Hyg. 2003 Nov-Dec;97(6):697-701.

PMID:
16117966
14.
15.

Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi.

Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, Kazembe PN, Djimdé AA, Kouriba B, Taylor TE, Plowe CV.

J Infect Dis. 2003 Jun 15;187(12):1870-5. Epub 2003 May 21.

16.

Resistance of Plasmodium falciparum malaria to chloroquine is widespread in eastern Afghanistan.

Rab MA, Freeman TW, Durrani N, de Poerck D, Rowland MW.

Ann Trop Med Parasitol. 2001 Jan;95(1):41-6.

PMID:
11235552
17.

Conquering the intolerable burden of malaria: what's new, what's needed: a summary.

Breman JG, Alilio MS, Mills A.

Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):1-15. Review.

19.

The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum.

Le Bras J, Durand R.

Fundam Clin Pharmacol. 2003 Apr;17(2):147-53. Review.

PMID:
12667224
20.
Items per page

Supplemental Content

Write to the Help Desk